Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Revenue	$ 0	$ 0
Costs and expenses:
Selling, general and administrative	1,793,000	765,000
Total	1,793,000	765,000
Operating income (loss)	(1,793,000)	(765,000)
Total other income (expense)
Interest income	9,000	(2,000)
Loss from loans to unconsolidated entities	524,000	47,000
Income (loss) from investments in unconsolidated entities, net	90,000	(2,000)
Total other expense	(425,000)	(51,000)
Profit (loss) before income taxes	(2,218,000)	(816,000)
Income tax benefit (provision) related to prior year	(163,000)	(0)
Net income (loss)	$ (2,055,000)	$ (816,000)
Basic and diluted net loss per share attributable to Elite Health Systems Inc. (in dollars per share)	$ (0.13)	$ (0.09)
Weighted average common shares outstanding, basic and diluted (in shares)	15,377,274	9,284,924